Tamoxifen Lowers Risk Of Invasive Breast Cancer
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Tamoxifen Lowers Risk Of Invasive Breast Cancer

LONDON, ENGLAND -- June 11, 1999 -- The introduction of mammography (breast screening) enabled better diagnosis of ductal carcinoma in situ (DCIS), a non-invasive cancer of the breast. Invasive cancer can develop in women who have DCIS and until the mid-1980s DCIS was treated frequently by mastectomy. Management, however, was changed after the publication of a study that showed lumpectomy plus radiation therapy to be similarly effective to mastectomy.

Professor Bernard Fisher and colleagues from Canada and the United States investigated whether treatment with lumpectomy and radiation therapy could be improved further by the addition of the drug Nolvadex (tamoxifen) to help to prevent invasive disease and they report their findings in this week's issue of The Lancet.

In the study, 1,804 women with DCIS were randomly assigned lumpectomy and radiation therapy, 902 women were assigned to five years of treatment with daily tamoxifen (20 mg) and 902 women assigned a placebo (an agent that has no effect). The investigators measured rates of all breast cancer events for five years, as well as the probability of developing invasive cancer in the same (ipsilateral) breast or the opposite (contralateral) breast.

After five years, there were fewer invasive breast-cancer events in the tamoxifen group than in the placebo group in the ipsilateral and contralateral breast and at distant and regional sites.

"The combination of lumpectomy, radiation therapy and tamoxifen was effective in the prevention of invasive cancer," the authors write.

Related Link: tamoxifen

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities